Medpage Today on MSN13d
For Your Patients: How Well Is Your Hives Treatment Working?
Is it working? Are your symptoms improving, staying the same, or getting worse? You may be asked to fill out a couple of ...
Verywell Health on MSN1y
The Best Options for Hives Treatment
Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...
PS on MSN18d
Hives vs. Rashes — How to Spot the Differences, According to Experts
Hives and rashes are two skin conditions that can look fairly similar. Here, experts explain the difference between hives and a rash, plus treatments.
Medscape23h
Dupilumab Beneficial When Antihistamines Fall Short for Chronic Spontaneous Urticaria
Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...
Monthly Prescribing Reference4d
FDA to Review Resubmitted Dupilumab sBLA for Chronic Spontaneous Urticaria
The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.